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Abstract. Background: NO and NO synthases (NOS) play
an important role in the physiology of the fetomaternal blood
circulation, although their expression in pathological
conditions is unclear. Intrauterine growth retardation (IUGR)
is a disorder most probably caused by abnormality of the
fetomaternal bloodflow. Materials and Methods: The
expression of endothelial NOS (ecNOS) from arteria
umbilicalis and the nitrite and peroxynitrite level of umbilical
blood were determined. Major consequences of peroxynitrite
toxicity are lipid peroxidation and glutathione depletion; these
parameters were also measured. Finally, superoxide
dismutase (SOD) activity was assayed to evaluate the level of
superoxide anions. Results: Elevated expression of ecNOS was
found to be coupled with significantly lower SOD activity and
glutathione level, and increased lipid peroxidation in IUGR
neonates. Conclusion: The increased NO indices could
represent a compensatory effort to improve placental
bloodflow, but in IUGR neonates it is coupled with inadequate
antioxidant defence, resulting in significant oxidative stress. 
Nitric oxide (NO) and NO synthases seem to play an
important role in the physiology of the fetomaternal blood
circulation, although their expression in pathological
conditions is unclear. NO has diverse functions in vivo. It is
fundamental in signaling via the production of cGMP by
guanylate cyclase (1). The production of NO is also
important for nonspecific immune response (2). NO
modulates blood flow, thrombosis and neural activity (3, 4).
NO also serves many important physiological roles in the
regulation of cardiac function including coronary
vasodilation, inhibiting platelet and neutrophil adhesion and
activation, modulation of cardiac contractile function, and
inhibiting cardiac oxygen consumption (5, 6). Most of the
cytotoxicity attributed to NO is due to peroxynitrite. It is
produced in a diffusion-controlled reaction between NO and
the free radical, the superoxide anion (7). Peroxynitrite
interacts with lipids, DNA and proteins via direct oxidative
reactions or indirect, radical-mediated mechanisms. In vivo,
superoxide is rapidly removed by high concentrations of
superoxide dismutases (SOD), so that the level of
peroxynitrite under physiological condition is controlled and
oxidative damage is minimized by endogenous antioxidant
defenses. Strict control is needed since peroxynitrite is a
strong oxidant which can react directly with electron-rich
groups, such as sulfhydryls (8), causing depletion in the
glutathione (GSH) pool.
Another mechanism of peroxynitrite-dependent cytotoxicity
relies on its ability to trigger lipid peroxidation (LP) in
membranes (9), causing membrane permeability and fluidity
changes, with significant biological consequences. The red
blood cell (RBC) membrane structure exhibits a special shape
and elasticity. Human RBCs are normally biconcave disks, but
when exposed to stress, they are known to undergo
deformation reversibly. In response to external forces, the
RBCs are deformed, but recover their resting shape when the
forces are removed (10). If the integrity of the membrane is
damaged, RBCs lose this shape and elasticity and may
undergo hemolysis, which sets back normal fetal development.
Hemoglobin binds not only O2, but also NO, which plays an
important role in blood flow regulation (11). In vivo, the
measurement of thiobarbituric acid (TBA)-reactive substances,
such as malondialdehyde (MDA) which is one of the products
of LP, has been used as an index of LP in pathological
conditions. The traditional TBA method for the determination
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of LP is not sufficiently specific for RBC membranes: the
method detects not only the products of membrane LP, but
also all the molecules which react with TBA. The
concentration of MDA correlates with oxidative lipid damage.
TBA reacts not only with MDA, but also with other aldehydes
from the intracellular area. 
In an abnormality such as intrauterine growth retardation
(IUGR), which is most probably a consequence of a disorder
of the fetomaternal blood circulation, clarifying the role of
NO is reasonable. A fetus or a newborn with IUGR weighs
less than 90%  of all other fetuses or newborns of the same
gestational age. The reported incidence of IUGR ranges
between 3 and 10% . This prevalent neonatal disorder is
associated with an increased level of morbidity and mortality.
The intrauterine environment has long-term effects on
subsequent health and survival of neonates. Studies
demonstrated a relationship between low birth weight and
later development of cardiovascular disease (12), impaired
glucose tolerance (13), higher systolic blood pressure and
triglyceride levels (14). Moreover, impaired growth in
infancy and rapid childhood weight gain exacerbate the
effects of impaired prenatal growth. 
The aim of this study was to clarify the role of NO and
nitrosative stress in the pathophysiology of IUGR. We
determined the nitrite and peroxynitrite level of umbilical
blood and the expression of endothelial NO synthase
(ecNOS) from the umbilical artery. Because major
consequences of peroxynitrite toxicity are lipid peroxidation
and glutathione depletion, these parameters were also
measured and confirmed by hemorheological tests. In
addition, the activity of SOD was assayed to estimate the
level of superoxide anions. In order to determine the lipid
damage to the membranes specifically, we prepared
erythrocyte ghosts and applied the TBA method only to the
membranes. To confirm the results, we determined the RBC
deformability by filtration tests in IUGR and control groups.
Materials and Methods
Sample collection. The blood samples were obtained from the
Department of Obstetrics and Gynecology at the Medical University
of Szeged, Hungary. The Ethics Committee of the Department of
Obstetrics and Gynecology, Faculty of Medicine, University of
Szeged approved the study protocol. Twenty-nine full-term neonates
of either sex, born between weeks 37 and 40 were selected, 17 of
them with normal weight (3,450±550 g) and 12 with symmetrical
IUGR (weight 2,000±350 g). In the studied group, there was a
multiple birth case: one of the twins was of normal weight (twin A)
and the other with IUGR (twin B). The pH of the blood samples was
in all cases in the range 7.24-7.39, i.e. there was no hypoxic stress on
the tissues. Newborns that had a history of difficult delivery and fetal
distress, or showed malformations or evidence of genetic disorders
were excluded. Hypoglycemia that occurred among the IUGR babies
was compensated by a 10%  glucose infusion. The nutritional status
of the mothers during pregnancy was satisfactory; no case of
malnutrition occurred. The mothers received complete pregnancy
care. Smoking mothers and their newborns had a higher
concentration of the carbonyl group, lipid peroxides and less total
antioxidant capacity. Newborns from these mothers weighed
significantly less than others at birth (15). Consequently, the
smoking mothers and their newborns were excluded from this study. 
Blood was taken from the umbilical artery of the placenta before
birth in both groups. Coagulation was inhibited by EDTA. The
duration of storage was as short as possible, with a maximum of a
week. The blood samples were kept at –20˚C until processing. The
blood samples were centrifuged at 1000×g for 10 min and the
plasma and the buffy coat were removed. The RBC phase was
washed twice with 2 volumes of isotonic saline solution at pH 7.0.
The RBCs were hemolysed by the addition of distilled water at a
ratio of 1:9. Except for SOD activity determinations, the aliquots of
the hemolysates were used directly. A Thermo Spectronic Biomate
5 was used for the spectrophotometric measurements.
For studying ecNOS expression, small pieces of the umbilical
artery were used. They were cut from the umbilical cord after the
blood sample collection, without any storage, and were processed
immediately since RNA degradation is very fast.
RNA extraction, reverse transcription and PCR amplification.
Approximately 100 mg of umbilical artery was homogenized in TRI
reagent (Sigma-Aldrich, Steinheim, Germany) and total RNA was
prepared according to the procedure suggested by the manufacturer. 
To follow the expression of ecNOS gene, semi-quantitative RT-
PCR was performed using β-actin as an internal control. First-strand
cDNA was synthesized using 5 μg total RNA as template. The RNA
was denaturated at 95˚C, mixed with 200 pmol of each dNTP
(Fermentas, Vilnius, Lithuania), 200U M-MuLV reverse
transcriptase (Fermentas) and 500 pmol random hexamer primers
in a final volume of 20 μl and incubated for 10 min at 37˚C,
followed by 45 min at 42˚C. 
A total of 1 μl of reverse transcription product was added to 49 μl
of PCR reaction mixture containing 250 μM dNTP, 50 pmol primers,
1× PCR buffer/MgCl2 and 5 U Taq polymerase (Fermentas).
Amplification was performed in a PTC 200 Peltier Thermal Cycler
(MJ Research, Watertown, MA, USA). The number of amplification
cycles during which PCR product formation was limited by the
template concentration was determined in pilot experiments: for 
β-actin this was 25 cycles and for ecNOS it was 32 cycles at 95˚C
for 30 s, 60˚C for 40 s and 72˚C for 60 s. The amplified products
were electrophoresed on 1.8%  agarose (Sigma) gel. 
For the β-actin mRNA used as internal reference, 25 cycles at
95˚C for 30 s 60˚C for 40 s and 72˚C for 60 s were used. The
relative level of ecNOS was expressed as a ratio of that to β-actin
(ecNOS/β-actin×100). 
The sequences of primers were derived from GenBank entry
M24113 for β-actin (forward: 5’gcaagagaggtatcctgacc3’ and reverse:
5’ccctcgtagatgggcacagt3’), and NM_000603 for ecNOS (forward:
5’gacattgagagcaaagggctg3’and reverse: 5’tgcggcttgtcacctcctgg3’)
Images of ethidium bromide-stained agarose gels were digitized with
a GDS 7500 Gel Documentation System and analyzed with the
GelBase/GelBlot™ Pro Gel Analysis Software (Ultra Violet Products
Ltd. Upland, CA). 
Nitrite and peroxynitrite assay. Plasma NO concentrations were
determined using Griess reagent (Sigma) according to the procedure
suggested by the manufacturer. 
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Peroxynitrite was assayed by diluting aliquots of blood samples
into 1.0 M NaOH and measuring the increase in absorbance at 302
nm. As a control, samples were added to 100 mM potassium
phosphate (pH 7.4). The decrease in absorbance was measured at
neutral pH as peroxynitrite decomposes (16). 
SOD activity assay. Before the determination of SOD activity (17), the
hemolysates were treated with ethanol:chloroform (2:1) to remove
hemoglobin from the samples and were then centrifuged at 3000×g. The
supernatants were used for SOD activity determinations via inhibition of
the epinephrine-adrenochrome transformation. The control sample
contained 2.9 ml of 0.05 M carbonate buffer (pH 10.2, warmed to 37˚C)
and 0.1 ml of epinephrine (16.5 mg/10 ml 0.1 N HCl). The absorbance
was measured at 480 nm for 3 minutes after a one-minute delay. The rate
of autoxidation of epinephrine (ΔA at 480 nm/min) was determined. To
measure the inhibition of autooxidation by SOD a mixture containing
2.875 ml of the carbonate buffer, 0.025 ml supernatant and 0.1 ml
epinephrine was used. Spectrophotometric measurement was carried out
at 480 nm. The results were expressed in U/mg protein.
The total quantity of protein was determined with Folin reagent,
using bovine serum albumin as standard (18).
GSH measurement. The GSH in the plasma and RBCs was measured
using Ellman’s reagent (DTNB). Proteins were precipitated with 5%
trichloroacetic acid (TCA) in order to omit protein-linked -SH
groups from the measurement (19).
LP assay. LP of the plasma and RBCs was determined using the
TBA method (20) which reveals the level of total TBA-reactive
substances, with slight modifications. Calibration was performed
with MDA. A volume of 2.7 ml of TBA reagent solution (a mixture
of 0.375%  TBA, 0.25 M HCl, 15%  TCA) was added to 0.3 ml of
the hemolysed blood sample, the components were mixed
vigorously and the mixture was heated for 15 min in a boiling
water-bath. Subsequently, the samples were cooled in ice-cold water
and centrifuged at 3000×g for 10 min; the absorbance of the
supernatant at 532 nm was measured spectrophotometrically to
calculate concentrations. The LP of the RBC membranes was also
measured by preparing erythrocyte ghosts (21). 
Deformability tests. For rheological (deformability) tests, 5%
hematocrit suspensions were prepared with PBS buffer at pH 7.4.
Measurements were performed with an M-100 filtrometer (Mikron,
Budapest, Hungary; constructed on the basis of the St. George
filtrometer) using a Nucleopore filter (Nucleopore Corp., USA)
with a diameter of 5 μm. A computer coupled to the filtrometer
calculated the relative filtration speed (Fi), the mean cell transit time
(Tc) and the clogging rate (CR) (13).
Statistical analysis. Statistical differences were calculated with one-
way analysis of variance (ANOVA) (MedCalc Statistical Software
version 9.4.2.0. Broekstraat, Belgium) with a Student–Newman–Keuls
post-hoc test. Significant difference was accepted at p<0.05. The
reported values are means±SD. 
Results
Expression of ecNOS. RT-PCR was performed on total RNA
extracted from the umbilical artery of IUGR and control
neonates. The expression of ecNOS in the control samples
was very low (Figure 1). The specific mRNA level varied
between undetected (n=7) and around 11%  of that of the β-
actin transcript (n=10). ecNOS mRNA was detectable in all
IUGR samples (n=12). The induced expression level
measured in neonates with IUGR showed individual
variation, with ecNOS/β-actin ratio between 0.3-0.6.
Nitrite, peroxynitrite and SOD activity. When both
superoxide and NO are present close to each other and in
abundance, they will combine spontaneously to form
peroxynitrite. Our results show significantly higher serum
nitrite and peroxynitrite levels in the IUGR group;
moreover, SOD activity was significantly lower in this
group which indicates an elevated level of superoxide
(Figure 2). 
LP assays. Based on the findings that peroxynitrite is a
major initiator of membrane damage and rapid oxidation of
GSH, we determined the level of LP and GSH in umbilical
blood samples of IUGR and control neonates. Not
surprisingly, a the level of peroxynitrite was higher in the
IUGR group, we also found a significant increase in the
level of LP. 
Lipid peroxidation of whole red blood cells and purified
membrane fractions of erythrocytes were determined (Figure
3). LP in the control group was 0.049 nmol MDA/mg
protein, while that in the IUGR group was 0.1064 nmol
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Figure 1. Detection of ecNOS mRNA from the umbilical artery of IUGR
(n=12) and control (n=17) samples. Four representative experiments
are presented. The difference was significant at **p<0.01.
MDA/mg protein. The corresponding LP data for the
erythrocyte ghost were 7.44 nmol MDA/ml in the control
group and 9.97 nmol MDA/ml in the IUGR group. 
Deformability test. Deformability tests were applied to RBC
suspensions to confirm the results of the LP assay. The relative
filtration speed, the cell transit time and the clogging rate were
determined by filtrometer. The results of filtration
measurements demonstrated the same tendencies (Figure 4).
The Fi rate was 0.66 μl/s, in the control group and 0.492 μl/s
in the IUGR group; Tc was 9.56 s/cell in the control and 11.69
s/cell in the IUGR neonates, while CR was 5.04×10–3 pores/μl
in the control and 3.14×10–3 pores/μl in the IUGR newborns.
Cells that cross the test membrane relatively quickly have an
intact membrane with adequate fluidity, thus our results show
that RBC membranes were altered in IUGR neonates.
GSH level. As the level of peroxynitrite was higher in the
IUGR group, we found a remarkable diminution in the GSH
level (Figure 5). The level of GSH was 6.22 nmol/mg protein
and 2.39 nmol/mg protein in the control and IUGR groups
respectively.
Discussion
IUGR is a neonatal disorder most probably caused by
abnormality of the fetomaternal blood flow. An important
finding of our present study is the different level of mRNA
expressions of ecNOS observed in IUGR and control
samples. We detected that ecNOS expression in the umbilical
artery in IUGR neonates was least 2-fold greater than that of
the control group.
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Figure 2. The level of nitrite (nmol/ml) and peroxynitrite (nmol/mg
protein) and the activity of SOD (EU/mg protein) in the IUGR (n=12)
and control (n=17) group. Differences were significant at *p<0.05,
**p<0.01.
Figure 3. The level of LP in RBC and RBC membrane fraction (LP
ghost) of IUGR (n=12) and control (n=17) umbilical cord blood
samples. Differences were significant at **p<0.01, ***p<0.001.
Figure 4. Rheological parameters Fi (relative filtration speed, μl/s), Tc
(cell transit time, s/cell), and CR (clogging rate, pores/μl) of red blood
cells of IUGR (n=17) and control neonates (n=12). Differences were
significant at *p<0.05.
Figure 5. The level of glutathione (GSH) in IUGR (n=12) and control
(n=17) umbilical cord blood samples. The differences were significant at
***p<0.001.
It is known that NO is generated from the metabolism of
arginine by NOS. It diffuses from endothelial cells to
underlying smooth muscle, where it activates the enzyme
guanylate cyclase and so increases cGMP production leading
to vascular relaxation. In the human fetomaternal circulation,
NO appears to contribute to the maintenance of low vascular
resistance (22).
Our result of elevated ecNOS expression in IUGR concurs
the studies demonstrating an increase in ecNOS or NO
production in the fetoplacental circulation of IUGR fetuses.
Lyall et al. (23) determined NO concentrations by measuring
indices of NO production in human umbilical venous blood
from IUGR and normal. They found in pregnancies
complicated by IUGR, umbilical venous plasma had
significantly higher nitrite and nitrate levels. Myatt et al.
(24) used a semiquantitative immunohistochemical technique
to show that basal levels of ecNOS were higher in placental
tissue in pregnancies complicated by IUGR or by both
preeclampsia and IUGR. 
In addition, we also determined the level of nitrite,
peroxynitrite, LP, GSH and SOD activity to provide more detail
regarding this question. We found that in IUGR neonates,
elevated expression of ecNOS is coupled with reduced SOD
activity. SOD is responsible for superoxide removal. The
deficiency of this activity increases superoxide levels. NO
reacts very fast with superoxide, forming the highly toxic and
stable peroxynitrite. It interacts with biomolecules, especially
lipids and GSH, via direct oxidative reactions. Our results of
GSH depletion and elevated LP confirm these suggestions.
GSH is one of the most important antioxidants. It plays
essential roles in antioxidant defence, as well as in maintenance
of the intracellular redox state.
Lipid peroxides may decrease membrane fluidity,
inactivate membrane-bound receptors and enzymes, and
increase the membrane permeability. The integrity of
erythrocyte membranes is especially important because it is
crucial for their transfer function. 
We conclude that the increase in NO indices could
represent a compensatory effort to improve placental blood
flow and decrease the peripherial pressure, but in IUGR
neonates, it is coupled with inadequate antioxidant defense,
resulting in significant oxidative stress. This oxidative
overload then plays important roles in the pathogenesis of
the fetal origins of adult disease. Severe oxidative stress can
modify the expression of genes in both differentiated and
pluripotential cells, which leads to disturbances in cell
proliferation and maturation. The fetus also adapts to an
inadequate redox status by metabolic changes, redistribution
of blood flow and changes in the production of fetal and
placental hormones which control growth. Accordingly, an
oxidative insult in the intrauterine milieu influences both
growth and development of the fetus and the subsequent
development of adult diseases. 
Adequate fetoplacental circulation is indispensable for the
proper development of the fetus and the increased production
of NO in IUGR neonates does help to improve this. However,
NO is still a problem for these fetuses, as it enhances oxidative
stress in the umbilical cord. Nevertheless, our findings indicate
a good potential for therapeutic approaches. Adequate
antioxidant therapy, after confirmation of these findings
through intervention studies, may decrease the indices of
oxidative stress arising from increased NO production.
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